期刊
JOURNAL OF VIROLOGY
卷 88, 期 1, 页码 763-767出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02687-13
关键词
-
类别
资金
- National Institutes of Health [1K01DA024654, R01 AI081668]
- University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI027763]
- DARE: Delaney AIDS Research Enterprise (DARE) [U19AI096109]
- CFAR Network of Integrated Systems [R24 AI067039]
- Swiss HIV Cohort Study Project 594
- Swiss National Science Foundation [324730-130865, 33CS30-134277]
- Swiss HIV Cohort Study Research Foundation
Alpha interferon (IFN-alpha) suppresses human immunodeficiency virus type 1 (HIV-1) replication in vitro by inducing cell-intrinsic retroviral restriction mechanisms. We investigated the effects of IFN-alpha/ribavirin (IFN-alpha/riba) treatment on 34 anti-HIV-1 restriction factors in vivo. Expression of several anti-HIV-1 restriction factors was significantly induced by IFN-alpha/riba in HIV/ hepatitis C virus (HCV)-coinfected individuals. Fold induction of cumulative restriction factor expression in CD4+ T cells was significantly correlated with viral load reduction during IFN-alpha/riba treatment (r(2) = 0.649; P < 0.016). Exogenous IFN-alpha induces supraphysiologic restriction factor expression associated with a pronounced decrease in HIV-1 viremia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据